“Tour n’ Cure, what are you waiting for?” With these words, English journalist and documentary filmmaker Tim Coleman ended a video message June 12, in which he relays his journey to being treated for the hepatitis C virus in Egypt, after having contracted it over 30 years ago.
Coleman said in the video that his particular treatment in England with what are being called revolutionary drugs would cost 120,000 British pounds (roughly $152,000) and that he has sought to get free treatment from the English National Health Service (NHS), but still has not received it. He said that during a trip to Cairo, he saw the Tour n’ Cure campaign ad and found out that the Egyptian campaign offers a complete course of hepatitis C medication for no more than 1,200 pounds ($1,500).
He said that he received free treatment in Egypt with the new drugs for six months starting Feb. 15, and feels much better.
He had applied to be treated under the NHS program in 2015. In part because the treatment is so expensive in Britain, NHS England is rationing care. It is planning to fund 10,0000 hepatitis C courses annually, although 160,000 people are estimated to have the disease in England. A 12-week course there can cost up to around $50,000; some patients require more than one course.
AL-MONITOR All-Access gives you unlimited access to all our journalism, the full Daily Briefing, exclusive interviews, premium newsletters, and live events — for less than $2/week.